Inhibrx Biosciences, Inc. (INBX)
NASDAQ: INBX · Real-Time Price · USD
13.45
-0.30 (-2.22%)
At close: May 30, 2025, 4:00 PM
13.47
+0.03 (0.19%)
After-hours: May 30, 2025, 4:00 PM EDT
Inhibrx Biosciences Market Cap
Inhibrx Biosciences has a market cap or net worth of $194.63 million as of May 30, 2025.
Market Cap
194.63M
Enterprise Value
86.88M
1-Year Change
n/a
Ranking
Category
Stock Price
$13.45
Market Cap Chart
Since the IPO on May 29, 2024, Inhibrx Biosciences's market cap has decreased from $198.24M to $194.63M, a decrease of -1.82%. That is a compound annual growth rate of -1.82%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 29, 2025 | 199.04M | -10.71% |
| Dec 31, 2024 | 222.93M | 12.46% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 651.06B |
| Johnson & Johnson | 368.73B |
| AbbVie | 328.06B |
| Novo Nordisk | 313.75B |
| UnitedHealth Group | 267.61B |
| Abbott Laboratories | 231.29B |
| Novartis AG | 221.98B |
| AstraZeneca | 219.74B |